关注
Junya Matsumoto
Junya Matsumoto
National Institute of Mental Health, National Center of Neurology and Psychiatry
在 ncnp.go.jp 的电子邮件经过验证 - 首页
标题
引用次数
年份
[11C] AZ10419096–a full antagonist PET radioligand for imaging brain 5-HT1B receptors
A Lindberg, S Nag, M Schou, A Takano, J Matsumoto, N Amini, ...
Nuclear Medicine and Biology 54, 34-40, 2017
102017
A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive …
H Yamada, M Motoyama, N Hasegawa, K Miura, J Matsumoto, K Ohi, ...
BJPsych Open 8 (3), e83, 2022
132022
Abnormal phospholipids distribution in the prefrontal cortex from a patient with schizophrenia revealed by matrix-assisted laser desorption/ionization imaging mass spectrometry
J Matsumoto, Y Sugiura, D Yuki, T Hayasaka, N Goto-Inoue, N Zaima, ...
Analytical and bioanalytical chemistry 400, 1933-1943, 2011
702011
Assessment of copy number variations in the
K Oshima, Y Kunii, H Yabe, J Matsumoto, A Wada, M Hino, T Hashimoto, ...
2015
Assessment of copy number variations in the brain genome of schizophrenia patients
M Sakai, Y Watanabe, T Someya, K Araki, M Shibuya, K Niizato, ...
Molecular cytogenetics 8, 1-9, 2015
502015
Association between globus pallidus volume and positive symptoms in schizophrenia.
S Ito, K Miura, M Miyayama, J Matsumoto, M Fukunaga, K Ishimaru, ...
Psychiatry & Clinical Neurosciences 76 (11), 2022
72022
Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study
N Yasui‐Furukori, H Muraoka, N Hasegawa, S Ochi, S Numata, H Hori, ...
Neuropsychopharmacology reports 42 (1), 3-9, 2022
202022
Association between the superior longitudinal fasciculus and perceptual organization and working memory: A diffusion tensor imaging study
D Koshiyama, M Fukunaga, N Okada, K Morita, K Nemoto, F Yamashita, ...
Neuroscience Letters 738, 135349, 2020
412020
Association of DNA Methylation of Taq1A in the DRD2 with Response to Aripiprazole in acute schizophrenia
I Miura, M Bundo, M Hino, S Horikoshi, H Hoshino, K Iwamoto, H Kaneko, ...
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 19, 236-236, 2016
12016
Association study between white matter microstructure and intelligence decline in schizophrenia
J Matsumoto, K Miura, M Fukunaga, K Nemoto, D Koshiyama, N Okada, ...
Clinical EEG and Neuroscience, 15500594211063314, 2021
32021
Association Study Between White Matter Microstructure and Intelligence Decline in Schizophrenia (Dec, 10.1177/15500594211063314, 2021)
J Matsumoto, K Miura, M Fukunaga
CLINICAL EEG AND NEUROSCIENCE 53 (6), 572-572, 2022
2022
Better adherence to guidelines among psychiatrists providing pharmacological therapy is associated with longer work hours in patients with schizophrenia
S Ito, K Ohi, Y Yasuda, M Fujimoto, H Yamamori, J Matsumoto, ...
Schizophrenia 9 (1), 78, 2023
2023
Cerebral cortical structural alteration patterns across four major psychiatric disorders in 5549 individuals
J Matsumoto, M Fukunaga, K Miura, K Nemoto, N Okada, N Hashimoto, ...
Molecular Psychiatry 28 (11), 4915-4923, 2023
82023
Change of prescription for patients with schizophrenia or major depressive disorder during admission: Real-world evidence from the Effectiveness of Guidelines for Dissemination …
N Hashimoto, N Yasui-Furukori, N Hasegawa, S Ishikawa, H Hori, H Iida, ...
2023
Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for …
N Hashimoto, N Yasui-Furukori, N Hasegawa, S Ishikawa, H Hori, H Iida, ...
BMC psychiatry 23 (1), 473, 2023
2023
Changes in the condition of psychiatric inpatients after the complex Fukushima disaster
A Wada, Y Kunii, J Matsumoto, S Itagaki, H Yabe, H Mashiko, SI Niwa
Fukushima Journal of Medical Science 59 (1), 39-42, 2013
102013
Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: real-world evidence from the Effectiveness of Guidelines for …
N Hashimoto, N Yasui-Furukori, N Hasegawa, S Ishikawa, S Numata, ...
Asian Journal of Psychiatry 63, 102744, 2021
312021
Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study
H Muraoka, F Kodaka, N Hasegawa, N Yasui-Furukori, K Fukumoto, ...
Asian Journal of Psychiatry 74, 103174, 2022
82022
Clozapine treatment is associated with higher prescription rate of antipsychotic monotherapy and lower prescription rate of other concomitant psychotropics: a real-world …
S Ochi, H Tagata, N Hasegawa, N Yasui-Furukori, J Iga, H Kashiwagi, ...
International Journal of Neuropsychopharmacology 25 (10), 818-826, 2022
132022
Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics: A Nationwide Real-World Study in Japan
T Onitsuka, T Okada, N Hasegawa, T Tsuboi, J Iga, N Yasui-Furukori, ...
Journal of Clinical Psychopharmacology 43 (4), 365-368, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20